ARTELO BIOSCIENCES, INC. Notes Payable, Current
ARTELO BIOSCIENCES, INC. (ARTL) had Notes Payable, Current of $29.72 thousand as of 2017-05-31, per its 10-Q filed 2017-07-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2017-07-21
- 2017-05-31: Notes Payable, Current $29.72K.
- 2017-02-28: Notes Payable, Current $29.57K.
| Period end | Notes Payable, Current |
|---|---|
| 2017-05-31 | $29.72K 10-Q · filed 2017-07-21 |
| 2017-02-28 | $29.57K 10-Q · filed 2017-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |